Ninety One UK Ltd Acquires 203,546 Shares of CME Group Inc (NASDAQ:CME)

Share on StockTwits

Ninety One UK Ltd lifted its holdings in shares of CME Group Inc (NASDAQ:CME) by 43.6% in the second quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 670,391 shares of the financial services provider’s stock after buying an additional 203,546 shares during the period. Ninety One UK Ltd’s holdings in CME Group were worth $108,965,000 as of its most recent filing with the SEC.

Other hedge funds have also made changes to their positions in the company. Public Employees Retirement Association of Colorado increased its holdings in shares of CME Group by 6.7% in the first quarter. Public Employees Retirement Association of Colorado now owns 68,159 shares of the financial services provider’s stock worth $11,785,000 after buying an additional 4,267 shares during the period. Benjamin F. Edwards & Company Inc. grew its position in CME Group by 25.6% during the 1st quarter. Benjamin F. Edwards & Company Inc. now owns 598 shares of the financial services provider’s stock worth $103,000 after acquiring an additional 122 shares during the last quarter. AE Wealth Management LLC increased its stake in CME Group by 23.8% in the 1st quarter. AE Wealth Management LLC now owns 8,825 shares of the financial services provider’s stock worth $1,526,000 after purchasing an additional 1,694 shares during the period. WASHINGTON TRUST Co purchased a new position in CME Group in the 1st quarter worth approximately $106,000. Finally, Bartlett & Co. LLC bought a new stake in CME Group in the first quarter valued at approximately $31,000. Institutional investors and hedge funds own 84.24% of the company’s stock.

CME stock traded up $2.02 during midday trading on Tuesday, hitting $168.10. The stock had a trading volume of 1,479,798 shares, compared to its average volume of 2,028,335. The firm has a market cap of $59.41 billion, a price-to-earnings ratio of 25.35, a price-to-earnings-growth ratio of 5.38 and a beta of 0.30. The business has a 50-day moving average of $169.61 and a two-hundred day moving average of $177.12. CME Group Inc has a 52-week low of $131.80 and a 52-week high of $225.36. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.02 and a quick ratio of 1.02.

CME Group (NASDAQ:CME) last issued its quarterly earnings results on Wednesday, July 29th. The financial services provider reported $1.63 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.62 by $0.01. CME Group had a net margin of 46.39% and a return on equity of 9.93%. The company had revenue of $1.18 billion during the quarter, compared to analyst estimates of $1.20 billion. During the same period last year, the business earned $1.76 EPS. CME Group’s quarterly revenue was down 7.1% compared to the same quarter last year. Research analysts predict that CME Group Inc will post 7.03 earnings per share for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, September 25th. Stockholders of record on Thursday, September 10th will be issued a dividend of $0.85 per share. The ex-dividend date is Wednesday, September 9th. This represents a $3.40 annualized dividend and a dividend yield of 2.02%. CME Group’s payout ratio is 50.00%.

Several research analysts recently commented on the stock. Bank of America decreased their target price on shares of CME Group from $194.00 to $180.00 and set a “neutral” rating on the stock in a research note on Friday, July 10th. Loop Capital began coverage on shares of CME Group in a research note on Friday. They set a “sell” rating and a $138.00 price objective for the company. Goldman Sachs Group dropped their target price on shares of CME Group from $175.00 to $170.00 and set a “neutral” rating for the company in a report on Monday, June 22nd. Credit Suisse Group boosted their price target on CME Group from $170.00 to $177.00 and gave the company a “neutral” rating in a report on Thursday, September 10th. Finally, BidaskClub cut CME Group from a “sell” rating to a “strong sell” rating in a report on Tuesday, July 14th. Five investment analysts have rated the stock with a sell rating, eight have issued a hold rating and seven have issued a buy rating to the stock. The stock currently has an average rating of “Hold” and an average price target of $185.06.

In other news, Director Martin J. Gepsman sold 5,000 shares of CME Group stock in a transaction dated Wednesday, September 2nd. The stock was sold at an average price of $173.52, for a total value of $867,600.00. Also, Director Charles P. Carey sold 8,000 shares of the company’s stock in a transaction dated Tuesday, August 11th. The stock was sold at an average price of $165.39, for a total transaction of $1,323,120.00. Over the last three months, insiders sold 15,900 shares of company stock worth $2,695,838. Insiders own 1.20% of the company’s stock.

About CME Group

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.

Read More: What is range trading?

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc (NASDAQ:CME).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.